First Real-World outcome data of SCLC in Germany – Data from the Clinical Research platform Into molecular testing, treatment and outcome of (non-)Small cell lung carcinoma Patients (CRISP; AIO-TRK-0315) 11. November 2022 M. Sebastian, M. Reck, R. Fischer, D. Christoph, C. Bernhardt, E. von der Heyde, A. Nusch, P. Ludwig, A. Hipper, J. Hanselmann, T. Medinger, A. Binninger, M. Jänicke, P. Christopoulos, C. Elender, A. Bethge, B. Seese, T. Gauler, C. F. Waller, 2022. Oncol Res Treat 2022;45(suppl 2):11–346 Download Patient-reported outcomes in patients with advanced NSCLC before and during the COVID-19 pandemic in the German prospective CRISP Registry real-world cohort (AIO-TRK-0315). M Sebastian, F Griesinger, E von der Heyde, S Dörfel, J Wiegand, C Schiefer, C Losem, M Jänicke, A Fleitz, S Zacharias, A Hipper, C… Weiterlesen Systemic treatment of advanced hepatocellular carcinoma in Germany – First results from the prospective national intersectoral cohort study JADE. Schröder, J., Berg, T., Freiberg-Richter, J., Schlenska-Lange, A., von der Heyde, E., Schuler, M.K., Uhlig, J., Weinberg, F., Potthoff, K., Jänicke, M., Hofmann, W.P., Pereira,… Weiterlesen